Previous studies have shown that histamine promotes the proliferation of ovarian cancer cells by regulating the expression of ERs, and this can be inhibited by using the ERα inhibitor AZD9496 and the ERβ agonist DNP. Here, ESR2 is linked to ovarian carcinoma.